Literature DB >> 26702164

The prevalence of albuminuria among diabetic patients in a primary care setting in Singapore.

Eng Sing Lee1, Wern Ee Tang1.   

Abstract

INTRODUCTION: Microalbuminuria is an early sign of kidney damage. The prevalence of microalbuminuria in Singapore has been reported to be 36.0%-48.5%. However, the prevalence of microalbuminuria reported in these studies was determined with one urine sample using a qualitative urine test. The aim of this study was to determine the prevalence of micro- and macroalbuminuria using a more stringent criterion of two positive quantitative urine albumin-creatinine ratio (ACR) tests.
METHODS: We conducted a cross-sectional study of patients with type 2 diabetes mellitus (T2DM) who were followed up at a primary care clinic in Singapore. Patients were diagnosed to have albuminuria if they had two positive ACR tests within a seven-month period.
RESULTS: A total of 786 patients with T2DM met the study's inclusion criteria. 55.7% were already on an angiotensin-converting enzyme inhibitor (ACEI) and/or angiotensin receptor blocker (ARB). The prevalence rates of micro- and macroalbuminuria were 14.2% and 5.7%, respectively. Patients with albuminuria were more likely to have hypertension (odds ratio [OR] 3.47, 95% confidence interval [CI] 1.55-7.80). Diabetics with poorer diabetic control (OR 1.88, 95% CI 1.26-2.79), and higher systolic (OR 1.69, 95% CI 1.14-2.49) and diastolic (OR 1.96, 95% CI, 1.20 to 3.22) blood pressures were more likely to have albuminuria.
CONCLUSION: In the present study, the prevalence of microalbuminuria is significantly lower than that previously reported in Singapore. The presence of hypertension, poor diabetic control and suboptimal blood pressure control are possible risk factors for albuminuria in patients with T2DM.

Entities:  

Keywords:  albuminuria; macroalbuminuria; microalbuminuria; prevalence; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 26702164      PMCID: PMC4678408          DOI: 10.11622/smedj.2015189

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  19 in total

Review 1.  Targets to retard the progression of diabetic nephropathy.

Authors:  Mark E Cooper; Karin Jandeleit-Dahm; Merlin C Thomas
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

2.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

Review 3.  Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?

Authors:  Seema Basi; Pierre Fesler; Albert Mimran; Julia B Lewis
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

4.  Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes mellitus in Singapore.

Authors:  A Y T Wu; C B Tan; P H K Eng; K T Tan; S C Lim; E K Tan
Journal:  Singapore Med J       Date:  2006-04       Impact factor: 1.858

5.  Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy.

Authors:  P K Christensen; S Larsen; T Horn; S Olsen; H H Parving
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

Review 6.  Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review.

Authors:  Christopher P Price; Ronald G Newall; James C Boyd
Journal:  Clin Chem       Date:  2005-07-14       Impact factor: 8.327

7.  The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease.

Authors:  G Dreyer; S Hull; Z Aitken; A Chesser; M M Yaqoob
Journal:  QJM       Date:  2009-01-15

8.  Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program.

Authors:  Ei Ei Khaing Nang; Chin Meng Khoo; E Shyong Tai; Su Chi Lim; Subramaniam Tavintharan; Tien Yin Wong; Derrick Heng; Jeannette Lee
Journal:  Am J Epidemiol       Date:  2009-04-30       Impact factor: 4.897

9.  Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.

Authors:  S-C Lim; A F Y Koh; S K Goh; C-L Chua; B-L Heng; T Subramaniam; C-F Sum
Journal:  Diabetes Obes Metab       Date:  2007-07       Impact factor: 6.577

Review 10.  Albuminuria: a target for treatment of type 2 diabetic nephropathy.

Authors:  Dick de Zeeuw
Journal:  Semin Nephrol       Date:  2007-03       Impact factor: 5.299

View more
  1 in total

1.  Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: A Japanese Non-Elderly Cohort Study.

Authors:  Sachiko Ono; Yosuke Ono; Daisuke Koide; Hideo Yasunaga
Journal:  J Epidemiol       Date:  2019-06-15       Impact factor: 3.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.